417 related articles for article (PubMed ID: 17496542)
1. A single minor histocompatibility antigen encoded by UGT2B17 and presented by human leukocyte antigen-A*2902 and -B*4403.
Terakura S; Murata M; Warren EH; Sette A; Sidney J; Naoe T; Riddell SR
Transplantation; 2007 May; 83(9):1242-8. PubMed ID: 17496542
[TBL] [Abstract][Full Text] [Related]
2. A human minor histocompatibility antigen resulting from differential expression due to a gene deletion.
Murata M; Warren EH; Riddell SR
J Exp Med; 2003 May; 197(10):1279-89. PubMed ID: 12743171
[TBL] [Abstract][Full Text] [Related]
3. Multicenter analyses demonstrate significant clinical effects of minor histocompatibility antigens on GvHD and GvL after HLA-matched related and unrelated hematopoietic stem cell transplantation.
Spierings E; Kim YH; Hendriks M; Borst E; Sergeant R; Canossi A; Oudshoorn M; Loiseau P; Dolstra H; Markiewicz M; Leffell MS; Pereira N; Kircher B; Turpeinen H; Eliaou JF; Gervais T; Laurin D; Enczmann J; Martinetti M; Thomson J; Oguz F; Santarone S; Partanen J; Siekiera U; Alessandrino EP; Kalayoglu S; Brand R; Goulmy E
Biol Blood Marrow Transplant; 2013 Aug; 19(8):1244-53. PubMed ID: 23756210
[TBL] [Abstract][Full Text] [Related]
4. The DBY gene codes for an HLA-DQ5-restricted human male-specific minor histocompatibility antigen involved in graft-versus-host disease.
Vogt MH; van den Muijsenberg JW; Goulmy E; Spierings E; Kluck P; Kester MG; van Soest RA; Drijfhout JW; Willemze R; Falkenburg JH
Blood; 2002 Apr; 99(8):3027-32. PubMed ID: 11929796
[TBL] [Abstract][Full Text] [Related]
5. A human minor histocompatibility antigen specific for B cell acute lymphoblastic leukemia.
Dolstra H; Fredrix H; Maas F; Coulie PG; Brasseur F; Mensink E; Adema GJ; de Witte TM; Figdor CG; van de Wiel-van Kemenade E
J Exp Med; 1999 Jan; 189(2):301-8. PubMed ID: 9892612
[TBL] [Abstract][Full Text] [Related]
6. Increased severity of acute graft versus host disease as a result of differential expression following a homozygous gene deletion.
Jervis S; Collins P; Tate D; Foster L; Bowman V; Adhern C; Bloor A; Yin J; Wynn R; Poulton K
Int J Immunogenet; 2013 Apr; 40(2):116-9. PubMed ID: 22726315
[TBL] [Abstract][Full Text] [Related]
7. A UGT2B17-positive donor is a risk factor for higher transplant-related mortality and lower survival after bone marrow transplantation.
Terakura S; Murata M; Nishida T; Emi N; Akatsuka Y; Riddell SR; Morishima Y; Kodera Y; Naoe T
Br J Haematol; 2005 Apr; 129(2):221-8. PubMed ID: 15813850
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of pretransplant donor anti-recipient cytotoxic and helper T lymphocyte responses as correlates of acute graft-vs.-host disease and survival after unrelated marrow transplantation.
Pei J; Martin PJ; Longton G; Masewicz S; Mickelson E; Petersdorf E; Anasetti C; Hansen J
Biol Blood Marrow Transplant; 1997 Aug; 3(3):142-9. PubMed ID: 9310191
[TBL] [Abstract][Full Text] [Related]
9. Multiple minor histocompatibility antigen-specific cytotoxic T lymphocyte clones can be generated during graft rejection after HLA-identical bone marrow transplantation.
Marijt WA; Kernan NA; Diaz-Barrientos T; Veenhof WF; O'Reilly RJ; Willemze R; Falkenburg JH
Bone Marrow Transplant; 1995 Jul; 16(1):125-32. PubMed ID: 7581111
[TBL] [Abstract][Full Text] [Related]
10. Isolation of human CD4/CD8 double-positive, graft-versus-host disease-protective, minor histocompatibility antigen-specific regulatory T cells and of a novel HLA-DR7-restricted HY-specific CD4 clone.
Eljaafari A; Yuruker O; Ferrand C; Farre A; Addey C; Tartelin ML; Thomas X; Tiberghien P; Simpson E; Rigal D; Scott D
J Immunol; 2013 Jan; 190(1):184-94. PubMed ID: 23225889
[TBL] [Abstract][Full Text] [Related]
11. UTY gene codes for an HLA-B60-restricted human male-specific minor histocompatibility antigen involved in stem cell graft rejection: characterization of the critical polymorphic amino acid residues for T-cell recognition.
Vogt MH; Goulmy E; Kloosterboer FM; Blokland E; de Paus RA; Willemze R; Falkenburg JH
Blood; 2000 Nov; 96(9):3126-32. PubMed ID: 11049993
[TBL] [Abstract][Full Text] [Related]
12. A novel HLA-A*3303-restricted minor histocompatibility antigen encoded by an unconventional open reading frame of human TMSB4Y gene.
Torikai H; Akatsuka Y; Miyazaki M; Warren EH; Oba T; Tsujimura K; Motoyoshi K; Morishima Y; Kodera Y; Kuzushima K; Takahashi T
J Immunol; 2004 Dec; 173(11):7046-54. PubMed ID: 15557202
[TBL] [Abstract][Full Text] [Related]
13. Bi-directional allelic recognition of the human minor histocompatibility antigen HB-1 by cytotoxic T lymphocytes.
Dolstra H; de Rijke B; Fredrix H; Balas A; Maas F; Scherpen F; Aviles MJ; Vicario JL; Beekman NJ; Ossendorp F; de Witte TM; van de Wiel-van Kemenade E
Eur J Immunol; 2002 Oct; 32(10):2748-58. PubMed ID: 12355426
[TBL] [Abstract][Full Text] [Related]
14. CTL clones isolated from an HLA-Cw-mismatched bone marrow transplant recipient with acute graft-versus-host disease.
Sugimoto K; Murata M; Terakura S; Naoe T
J Immunol; 2009 Nov; 183(9):5991-8. PubMed ID: 19812210
[TBL] [Abstract][Full Text] [Related]
15. Tetrameric HLA class I-minor histocompatibility antigen peptide complexes demonstrate minor histocompatibility antigen-specific cytotoxic T lymphocytes in patients with graft-versus-host disease.
Mutis T; Gillespie G; Schrama E; Falkenburg JH; Moss P; Goulmy E
Nat Med; 1999 Jul; 5(7):839-42. PubMed ID: 10395333
[TBL] [Abstract][Full Text] [Related]
16. A CD8 DE loop peptide analog prevents graft-versus-host disease in a multiple minor histocompatibility antigen-mismatched bone marrow transplantation model.
Choksi S; Kim JC; Whitaker-Menezes D; Murphy GF; Friedman TM; Korngold R
Biol Blood Marrow Transplant; 2004 Oct; 10(10):669-80. PubMed ID: 15389433
[TBL] [Abstract][Full Text] [Related]
17. Optimized Whole Genome Association Scanning for Discovery of HLA Class I-Restricted Minor Histocompatibility Antigens.
Fuchs KJ; Honders MW; van der Meijden ED; Adriaans AE; van der Lee DI; Pont MJ; Monajemi R; Kielbasa SM; 't Hoen PAC; van Bergen CAM; Falkenburg JHF; Griffioen M
Front Immunol; 2020; 11():659. PubMed ID: 32362897
[TBL] [Abstract][Full Text] [Related]
18. Lack of recognition of HLA class I mismatches outside α1/α2 domains by CD8+ alloreactive T lymphocytes: the HLA-B44 paradigm.
Bettens F; Schanz U; Tiercy JM
Tissue Antigens; 2013 Jun; 81(6):414-8. PubMed ID: 23488546
[TBL] [Abstract][Full Text] [Related]
19. The HLA-A*0201-restricted minor histocompatibility antigen HA-1H peptide can also be presented by another HLA-A2 subtype, A*0206.
Torikai H; Akatsuka Y; Miyauchi H; Terakura S; Onizuka M; Tsujimura K; Miyamura K; Morishima Y; Kodera Y; Kuzushima K; Takahashi T
Bone Marrow Transplant; 2007 Jul; 40(2):165-74. PubMed ID: 17530010
[TBL] [Abstract][Full Text] [Related]
20. Identification of a graft versus host disease-associated human minor histocompatibility antigen.
den Haan JM; Sherman NE; Blokland E; Huczko E; Koning F; Drijfhout JW; Skipper J; Shabanowitz J; Hunt DF; Engelhard VH
Science; 1995 Jun; 268(5216):1476-80. PubMed ID: 7539551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
